
Auteur S. BAJIS
|
Documents disponibles écrits par cet auteur (2)

E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : PériodiqueBackground: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]
S. BAJIS ; G. J. DORE ; B. HAJARIZADEH ; E. B. CUNNINGHAM ; L. MAHER ; J. GREBELY | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueBackground: The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to[...]